OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implications of Toll-like receptors in Ebola infection
Amene Saghazadeh, Nima Rezaei
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 4, pp. 415-425
Closed Access | Times Cited: 25

Showing 25 citing articles:

Role of Toll‐like receptors in the pathogenesis of COVID‐19
Shaghayegh Khanmohammadi, Nima Rezaei
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 2735-2739
Open Access | Times Cited: 317

Immune-epidemiological parameters of the novel coronavirus – a perspective
Amene Saghazadeh, Nima Rezaei
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 5, pp. 465-470
Open Access | Times Cited: 223

Noncoding RNA (ncRNA)-mediated regulation of TLRs: critical regulator of inflammation in tumor microenvironment
Tawfeeq Alghazali, Abdulrahman T. Ahmed, Uday Abdul‐Reda Hussein, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access | Times Cited: 2

Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
Arefeh Basiri, Zahra Pazhouhnia, Nima Beheshtizadeh, et al.
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 163-175
Open Access | Times Cited: 79

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach
Morteza Alizadeh, Hossein Amini‐Khoei, Shahram Tahmasebian, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 45

Poxviruses and the immune system: Implications for monkeypox virus
Amene Saghazadeh, Nima Rezaei
International Immunopharmacology (2022) Vol. 113, pp. 109364-109364
Open Access | Times Cited: 39

RNA viruses, TLRs, and cytokines: the perfect storm?
Sophia K. Stegeman, Olena Kourko, Heather Amsden, et al.
Journal of Innate Immunity (2025) Vol. 17, Iss. 1, pp. 126-153
Open Access

Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection
Uma Shankar, Neha Jain, Subodh Kumar Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 11, pp. 4815-4831
Closed Access | Times Cited: 18

Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge
Nima Rezaei, Saboura Ashkevarian, Mahsa Keshavarz Fathi, et al.
Advances in experimental medicine and biology (2021), pp. 1-22
Closed Access | Times Cited: 15

Extracellular vesicle storm during the course of Ebola virus infection in primates
Andrea Vucetic, Andrea Lafleur, Marceline Côté, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4

Ebolavirus interferon antagonists—protein interaction perspectives to combat pathogenesis
Anupam Banerjee, Abantika Pal, Debnath Pal, et al.
Briefings in Functional Genomics (2017)
Open Access | Times Cited: 9

Curcumin attenuates poly(I:C)-induced immune and inflammatory responses in mouse macrophages by inhibiting TLR3/TBK1/IFNB cascade
Xue Zhang, Liang Chen, Chun Hu, et al.
Journal of Functional Foods (2022) Vol. 89, pp. 104949-104949
Open Access | Times Cited: 6

Synthesis and studies of new purines/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system
Gurmeet Kaur, Manisha Bansal, Hafiz Muzzammel Rehman, et al.
Molecular Diversity (2023) Vol. 28, Iss. 1, pp. 97-110
Open Access | Times Cited: 3

Immunoinformatics-Driven Multiepitope Vaccine Targeting Streptococcus mutans for Dental Caries Prevention
Bandana Devi Pangabam, Romen Singh Naorem, Anju Barhai Teli, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3

Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV
Mahzad Akbarpour, Laleh Sharifi, Amir Reza Safdarian, et al.
Advances in experimental medicine and biology (2021), pp. 149-167
Closed Access | Times Cited: 5

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
Lin Xu, Daniela Tudor, Morgane Bomsel
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 4

Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses
Sami I. Ali, Abeer Salama
Advances in experimental medicine and biology (2024), pp. 337-354
Closed Access

TLR4 TIR domain and nucleolin GAR domain synergistically mediate RSV infection and induce neuronal inflammatory damage in SH‐SY5Y cells
Chengcheng Jiang, Yixuan Huang, Hongya Gui, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access

In silico designed novel multi epitope vaccine construct towards Bundibugyo Ebolavirus
Rajaguru Arivuselvam, A. Mohamed Sheik Tharik, S. Santhosh, et al.
Vacunas (2022) Vol. 23, Iss. 3, pp. 194-207
Closed Access | Times Cited: 2

Role of Toll-like receptors in COVID-19 pathogenesis
I. А. Sinyakin, I. А. Аndrievskaya, Н. А. Ишутина, et al.
Bulletin physiology and pathology of respiration (2021), Iss. 82, pp. 107-115
Open Access | Times Cited: 2

Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3.
Hamid Asadzadeh Aghdaei, Negar Jamshidi, Vahid Chaleshi, et al.
PubMed (2021) Vol. 14, Iss. 4, pp. 295-303
Closed Access | Times Cited: 2

In silico designed novel multi epitope vaccine construct towards Bundibugyo Ebolavirus
Rajaguru Arivuselvam, A. Mohamed Sheik Tharik, S. Santhosh, et al.
Vacunas (English Edition) (2022) Vol. 23, Iss. 3, pp. 194-207
Closed Access

Page 1

Scroll to top